AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

MOBEUS INCOME & GROWTH 4 VCT PLC

Regulatory Filings Jul 3, 2019

4782_rns_2019-07-03_516684e0-b394-43af-bdc0-151733a9e323.html

Regulatory Filings

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 3715E

Mobeus Income & Growth 4 VCT PLC

03 July 2019

Mobeus Income & Growth 4 VCT plc

(the "Company")

Realisation of investment in ASL Technology Holdings Limited

The Company is pleased to announce the sale of its investment in ASL Technology Holdings Limited ("ASL") to a trade purchaser on a debt free and cash free basis.  The Company received £3.40 million in cash from the sale, and generated a realised gain over cost over the life of the investment of £2.29 million, being the equivalent of 3.38 pence per share.

In isolation, the impact of this sale on the Company's latest announced NAV per share of 83.59 pence at 31 March 2019 (adjusted for the subsequent payment of a dividend of 4 pence per share on 28 May 2019), would be an increase of 0.67 pence per share.

All four Mobeus-advised VCTs realised their investment in ASL.  Total cash proceeds received by the four Mobeus-advised VCTs over the life of their investment in ASL are £21.15 million, against an original investment cost of £9.69 million. This represents a return of 2.18 times the original investment cost and an IRR of over 12.6% for each VCT in the eight and a half years that this investment was held.

For further information, please contact:

Robert Brittain, for Mobeus Equity Partners LLP, Company Secretary 020 7024 7600

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

MSCCKNDNKBKDKOK

Talk to a Data Expert

Have a question? We'll get back to you promptly.